Loading clinical trials...
Loading clinical trials...
Gonadotrophin Releasing Hormone Agonist for Dual Trigger in in Vitro Fertilization and for Luteal Phase Support in Frozen-thawed Embryo Transfer
Conditions
Interventions
IVF: Decapeptyl and hCG
FET: Decapeptyl
+2 more
Locations
1
China
Department of Obstetrics and Gynaecology
Hong Kong, Hong Kong, China
Start Date
September 1, 2019
Primary Completion Date
September 1, 2024
Completion Date
March 30, 2025
Last Updated
December 6, 2024
NCT03859921
NCT05896709
NCT05876234
NCT06795568
NCT04538560
NCT02748278
Lead Sponsor
The University of Hong Kong
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions